Simplex Castings Ltd has announced a major capital expansion plan, seeking to raise approximately Rs 99.7 crore through the preferential allotment of equity shares and convertible warrants at Rs 105 per unit. The board has also approved increasing the authorized share capital to Rs 15 crore to accommodate the move. An Extraordinary General Meeting (EGM) is set for October 15, 2026, to secure shareholder approval for these resolutions, with a voting cut-off date of October 8, 2026.
Simplex Castings Announces Rs 99.7 Crore Capital Infusion
Simplex Castings will raise Rs 99.7 crore through equity and warrants at Rs 105 per share.
Authorized capital is set to increase from Rs 10 crore to Rs 15 crore.
Reader Takeaway: Significant equity dilution incoming; capital expansion signals growth ambitions but requires critical shareholder approval on October 15.
What just happened
The board of Simplex Castings Ltd has approved a two-pronged fundraising strategy aimed at strengthening the company's financial position. The plan includes the issuance of up to 44,90,791 equity shares and 50,05,195 convertible warrants, both priced at Rs 105 per unit. This collective issuance is expected to bring in roughly Rs 99.7 crore in capital. To facilitate this, the board has proposed an increase in the company's authorized share capital from Rs 10 crore to Rs 15 crore, involving an amendment to the Memorandum of Association.
Why this matters
This capital injection provides the company with substantial liquidity to fund its operations or potential growth initiatives. The issuance of convertible warrants provides an 18-month window for conversion, suggesting a staged approach to equity infusion. The governance structure also sees a change with the appointment of Mr. Urlam Jaya Manmadha Rao, a veteran with 46 years of experience, as a Non-Executive Independent Director, adding significant oversight experience to the board.
EGM and Voting
Shareholders are invited to vote on these proposals at the upcoming Extraordinary General Meeting (EGM) scheduled for October 15, 2026. The meeting will be held via video conferencing. Investors looking to participate in the remote e-voting process must ensure they are on the register of members by the cut-off date of October 8, 2026.
Risks to watch
Investors should monitor the dilution impact on existing shareholding once the warrants are converted. Additionally, the success of this fundraising is strictly contingent on obtaining necessary shareholder approvals at the upcoming EGM. The conversion of warrants within 18 months remains dependent on market conditions and the company’s performance during that period.
What to track next
The primary event to watch is the October 15, 2026, EGM. Investors should also track subsequent filings regarding the actual allotment of shares and any future disclosures regarding the specific usage of the newly raised funds.